{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:30:03Z","timestamp":1760149803442,"version":"build-2065373602"},"reference-count":39,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T00:00:00Z","timestamp":1695168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCDD"],"abstract":"<jats:p>As a person ages, mitral annular calcification develops in the mitral annulus with increasing frequency. Lipid deposition, inflammation, and aging-related degeneration have been cited as potential causes of this pathophysiology, though there is currently no conclusive evidence to support this. AGEs accumulate in tissues due to the glycation of proteins and lipids, increasing the release of proinflammatory cytokines secondary to oxidative stress through the AGE receptor. The AGE levels increase in diabetic microvascular complications and degenerative aortic valve disease. Our study was planned prospectively as a case\u2013control study involving 94 MAC-positive patients and 94 MAC-negative patients. The demographics, echocardiographic data and AGE levels of the patients were measured and recorded using the skin autofluorescence method. AGE levels were significantly higher in the MAC-positive patient group (3.2 vs. 2.7; p &lt; 0.001). The AGE levels were observed as an independent predictor of MAC development in a regression analysis (OR: 8.05, 95% CI: 3.74\u201317.33, p &lt; 0.001). In a ROC-curve analysis, the AUC was 0.79 (95% CI: 0.72\u20130.85). At a cut-off value of 2.7, 79.7% sensitivity and 69.1% specificity were observed. AGE levels can be used to cheaply, easily and non-invasively identify patients at risk of developing MAC.<\/jats:p>","DOI":"10.3390\/jcdd10090406","type":"journal-article","created":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T21:47:03Z","timestamp":1695246423000},"page":"406","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Role of Advanced Glycation End-Product Levels Measured by Skin Autofluorescence in the Development of Mitral Annular Calcification"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1831-182X","authenticated-orcid":false,"given":"Bedrettin","family":"Boyraz","sequence":"first","affiliation":[{"name":"Cardiology Department, Medicalpark Hospital, Health Science Faculty, Mudanya University, Bursa 16950, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tezcan","family":"Peker","sequence":"additional","affiliation":[{"name":"Cardiology Department, Medicalpark Hospital, Health Science Faculty, Mudanya University, Bursa 16950, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,9,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1161\/01.CIR.0000058168.26163.BC","article-title":"Mitral annular calcification predicts cardiovascular morbidity and mortality: The Framingham Heart Study","volume":"107","author":"Fox","year":"2003","journal-title":"Circulation"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jcmg.2016.09.001","article-title":"Severe mitral annular calcification: Multimodality imaging for therapeutic strategies and interventions","volume":"9","author":"Eleid","year":"2016","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.tcm.2019.07.011","article-title":"Mechanisms of mitral annular calcification","volume":"30","author":"Massera","year":"2020","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0022-5223(96)70332-X","article-title":"Extensive calcification of the mitral valve anulus: Pathology and surgical management","volume":"111","author":"Carpentier","year":"1996","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1111\/echo.15236","article-title":"Prevalence of mitral annular calcification and its association with mitral valvular disease","volume":"38","author":"Okura","year":"2021","journal-title":"Echocardiography"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ijcard.2004.03.044","article-title":"Usefulness of helical computed tomography in detection of mitral annular calcification as a marker of coronary artery disease","volume":"101","author":"Adler","year":"2005","journal-title":"Int. J. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"256","DOI":"10.5603\/CJ.a2021.0076","article-title":"Association between mitral annulus calcification and subtypes of heart failure rehospitalization","volume":"30","author":"Kato","year":"2021","journal-title":"Cardiol. J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.ahj.2013.08.015","article-title":"Risk factors associated with the incidence and progression of mitral annulus calcification: The multi-ethnic study of atherosclerosis","volume":"166","author":"Elmariah","year":"2013","journal-title":"Am. Heart J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1540-8175.2006.00300.x","article-title":"The relation between mitral annular calcification and mortality in patients undergoing diagnostic coronary angiography","volume":"23","author":"Willens","year":"2006","journal-title":"Echocardiography"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jtcvs.2018.05.099","article-title":"Current and evolving strategies in the management of severe mitral annular calcification","volume":"157","author":"Bedeir","year":"2019","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1016\/j.jacc.2015.08.872","article-title":"Mitral annulus calcification","volume":"66","author":"Abramowitz","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.fshw.2021.12.012","article-title":"Management of Maillard reaction-derived reactive carbonyl species and advanced glycation end products by tea and tea polyphenols","volume":"11","author":"Luo","year":"2022","journal-title":"Food Sci. Hum. Wellness"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Reddy, V.P., Aryal, P., and Darkwah, E.K. (2022). Advanced glycation end products in health and disease. Microorganisms, 10.","DOI":"10.3390\/microorganisms10091848"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.drudis.2006.05.016","article-title":"Inhibitors of the Maillard reaction and AGE breakers as therapeutics for multiple diseases","volume":"11","author":"Reddy","year":"2006","journal-title":"Drug Discov. Today"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"17288","DOI":"10.3390\/molecules200917288","article-title":"Effect of Amaranthus on advanced glycation end-products induced cytotoxicity and proinflammatory cytokine gene expression in SH-SY5Y cells","volume":"20","author":"Amornrit","year":"2015","journal-title":"Molecules"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Shen, C.Y., Wu, C.H., Lu, C.H., Kuo, Y.M., Li, K.J., Hsieh, S.C., and Yu, C.L. (2019). Advanced glycation end products of bovine serum albumin suppressed Th1\/Th2 cytokine but enhanced monocyte IL-6 gene expression via MAPK-ERK and MyD88 transduced NF-\u03baB p50 signaling pathways. Molecules, 24.","DOI":"10.3390\/molecules24132461"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3818196","DOI":"10.1155\/2020\/3818196","article-title":"Advanced Glycation End Products (AGEs): Biochemistry, Signaling, Analytical Methods, and Epigenetic Effects","volume":"2020","author":"Perrone","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4330\/wjc.v4.i4.90","article-title":"Role of advanced glycation end products in cardiovascular disease","volume":"4","author":"Hegab","year":"2012","journal-title":"World J. Cardiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1515\/cclm-2012-0832","article-title":"Advanced glycation end-products and skin autofluorescence in end-stage renal disease: A review","volume":"52","author":"Arsov","year":"2014","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Lee, J., Yun, J.S., and Ko, S.H. (2022). Advanced glycation end products and their effect on vascular complications in type 2 Diabetes mellitus. Nutrients, 14.","DOI":"10.3390\/nu14153086"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/s41598-019-39202-5","article-title":"Intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular disease","volume":"9","author":"Takata","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fcvm.2020.00037","article-title":"Receptor for advanced glycation end products (RAGE) and mechanisms and therapeutic opportunities in diabetes and cardiovascular disease: Insights from human subjects and animal models","volume":"7","author":"Yepuri","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1901290","DOI":"10.1002\/mnfr.201901290","article-title":"Reduction in circulating advanced glycation end products by mediterranean diet is associated with increased likelihood of type 2 diabetes remission in patients with coronary heart disease: From the cordioprev study","volume":"65","author":"Cardelo","year":"2021","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"736040","DOI":"10.3389\/fcvm.2021.736040","article-title":"Sex Differences in Mitral Annular Calcification and the Clinical Implications","volume":"8","author":"Seo","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s41440-021-00847-3","article-title":"AGEs and renal sodium handling: Association with hypertension","volume":"45","author":"Suzuki","year":"2022","journal-title":"Hypertens. Res. Off. J. Jpn. Soc. Hypertens."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13098-022-00895-w","article-title":"The association between advanced glycation end products (AGEs) and ABC (hemoglobin A1C, blood pressure, and low-density lipoprotein cholesterol) control parameters among patients with type 2 diabetes mellitus","volume":"14","author":"Rezaei","year":"2022","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11883-020-0825-3","article-title":"Mitral Annular Calcification: Association with Atherosclerosis and Clinical Implications","volume":"22","author":"Cavalcanti","year":"2020","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Sanchis, P., Rivera, R., Fortuny, R., R\u00edo, C., Mas-Gelabert, M., Gonzalez-Freire, M., Grases, F., and Masmiquel, L. (2020). Role of Advanced Glycation End Products on Aortic Calcification in Patients with Type 2 Diabetes Mellitus. J. Clin. Med., 9.","DOI":"10.20944\/preprints202005.0341.v1"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"111088","DOI":"10.1016\/j.exger.2020.111088","article-title":"AGEs-RAGE axis causes endothelial-to-mesenchymal transition in early calcific aortic valve disease via TGF-\u03b21 and BMPR2 signaling","volume":"141","author":"Deng","year":"2020","journal-title":"Exp. Gerontol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/MED.0000000000000471","article-title":"Risk factors for valvular calcification","volume":"26","author":"Chen","year":"2019","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1476-7120-5-14","article-title":"Mitral annulus calcification is associated with valvular and cardiac structural abnormalities","volume":"5","author":"Movahed","year":"2007","journal-title":"Cardiovasc. Ultrasound"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.atherosclerosis.2003.12.018","article-title":"Mitral annular calcification is a predictor for incident atrial fibrillation","volume":"173","author":"Fox","year":"2004","journal-title":"Atherosclerosis"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/europace\/euu265","article-title":"Mitral annular calcification and incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis","volume":"17","author":"Efird","year":"2015","journal-title":"Europace"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1161\/hc3801.097806","article-title":"Improved arterial compliance by a novel advanced glycation end-product crosslink breaker","volume":"104","author":"Kass","year":"2012","journal-title":"Circulation"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cardfail.2004.09.010","article-title":"The effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure","volume":"11","author":"Little","year":"2005","journal-title":"J. Card. Fail."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/HJH.0b013e328013e7dd","article-title":"Advanced glycation endproduct crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension","volume":"25","author":"Zieman","year":"2007","journal-title":"J. Hypertens."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/eurjhf\/hfp207","article-title":"Effects of alagebrium, an advanced glycation end-product breaker, in patients with chronic heart failure: Study design and baseline characteristics of the BENEFICIAL trial","volume":"12","author":"Willemsen","year":"2010","journal-title":"Eur. J. Heart Fail."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.exger.2013.10.009","article-title":"The effect of an advanced glycation end-product crosslink breaker and exercise training on vascular function in older individuals: A randomized factorial design trial","volume":"48","author":"Rikkert","year":"2013","journal-title":"Exp. Gerontol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1161\/CIRCHEARTFAILURE.113.000440","article-title":"Cardiovascular effects of 1 year of alagebrium and endurance exercise training in healthy older individuals","volume":"6","author":"Fujimoto","year":"2013","journal-title":"Circ. Heart Fail."}],"container-title":["Journal of Cardiovascular Development and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2308-3425\/10\/9\/406\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:54:10Z","timestamp":1760129650000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2308-3425\/10\/9\/406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,20]]},"references-count":39,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["jcdd10090406"],"URL":"https:\/\/doi.org\/10.3390\/jcdd10090406","relation":{},"ISSN":["2308-3425"],"issn-type":[{"type":"electronic","value":"2308-3425"}],"subject":[],"published":{"date-parts":[[2023,9,20]]}}}